Lansforsakringar Fondforvaltning AB publ Makes New $109.35 Million Investment in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Lansforsakringar Fondforvaltning AB publ purchased a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 209,489 shares of the medical equipment provider's stock, valued at approximately $109,345,000. Intuitive Surgical accounts for approximately 1.3% of Lansforsakringar Fondforvaltning AB publ's holdings, making the stock its 15th largest holding. Lansforsakringar Fondforvaltning AB publ owned approximately 0.06% of Intuitive Surgical as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also made changes to their positions in ISRG. Norges Bank bought a new stake in Intuitive Surgical during the fourth quarter worth $2,401,493,000. Proficio Capital Partners LLC lifted its stake in Intuitive Surgical by 89,098.8% during the fourth quarter. Proficio Capital Partners LLC now owns 949,967 shares of the medical equipment provider's stock worth $495,845,000 after purchasing an additional 948,902 shares during the last quarter. Capital Research Global Investors lifted its stake in Intuitive Surgical by 25.5% during the fourth quarter. Capital Research Global Investors now owns 3,381,302 shares of the medical equipment provider's stock worth $1,764,904,000 after purchasing an additional 687,906 shares during the last quarter. Raymond James Financial Inc. bought a new stake in Intuitive Surgical during the fourth quarter worth $313,769,000. Finally, Northern Trust Corp lifted its stake in Intuitive Surgical by 15.8% during the fourth quarter. Northern Trust Corp now owns 3,619,293 shares of the medical equipment provider's stock worth $1,889,126,000 after purchasing an additional 494,496 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors.

Intuitive Surgical Stock Performance

Intuitive Surgical stock traded down $4.61 during mid-day trading on Friday, reaching $551.14. The company's stock had a trading volume of 2,091,011 shares, compared to its average volume of 1,646,559. Intuitive Surgical, Inc. has a 12-month low of $397.47 and a 12-month high of $616.00. The company has a market capitalization of $197.54 billion, a P/E ratio of 85.98, a PEG ratio of 5.85 and a beta of 1.70. The firm's fifty day moving average price is $516.44 and its two-hundred day moving average price is $538.55.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, beating analysts' consensus estimates of $1.71 by $0.10. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. The business had revenue of $2.25 billion during the quarter, compared to analyst estimates of $2.19 billion. During the same period in the previous year, the business earned $1.50 EPS. On average, research analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities research analysts have weighed in on ISRG shares. Robert W. Baird cut their target price on Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating for the company in a research note on Wednesday, April 23rd. Piper Sandler lowered their price target on shares of Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating for the company in a report on Wednesday, April 23rd. Truist Financial lowered their price target on shares of Intuitive Surgical from $605.00 to $590.00 and set a "buy" rating for the company in a report on Wednesday, April 23rd. Citigroup reiterated a "buy" rating and set a $650.00 price target (up from $590.00) on shares of Intuitive Surgical in a report on Thursday, May 22nd. Finally, Erste Group Bank downgraded shares of Intuitive Surgical from a "strong-buy" rating to a "hold" rating in a report on Monday, March 17th. Five investment analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company. According to MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus price target of $596.05.

Insider Activity at Intuitive Surgical

In other news, VP Fredrik Widman sold 810 shares of Intuitive Surgical stock in a transaction on Monday, March 3rd. The shares were sold at an average price of $573.78, for a total transaction of $464,761.80. Following the completion of the sale, the vice president now directly owns 473 shares of the company's stock, valued at approximately $271,397.94. The trade was a 63.13% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, SVP Mark Brosius sold 492 shares of Intuitive Surgical stock in a transaction on Monday, March 3rd. The stock was sold at an average price of $573.78, for a total transaction of $282,299.76. Following the sale, the senior vice president now directly owns 4,056 shares of the company's stock, valued at $2,327,251.68. This represents a 10.82% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 30,111 shares of company stock worth $15,364,055. Corporate insiders own 0.70% of the company's stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.